Protecting pharmaceuticals and biotechnology inventions in Europe

1

In view of the changing scenario of IP in India and the increasing number of international patent filings by Indian biotech and pharma companies, IP practitioners and experts, whether in private practice or industry, should be familiar with the latest developments at the EPO – the patent office for Europe - as far as filing, prosecution and examination procedures and practices in the field of pharma/biotech are concerned.

The seminar will provide a unique opportunity to gain a deep insight into the Pharma/Biotech practice in Europe and to interact with leading EPO experts on the subject matter, in particular Dr. A. Stamatopoulos, Principal Director Biotechnology / PAOC, Dr Dieter Tzschoppe, Director Pharma, and Mr. Klaus-Peter Döpfer, Director Biotechnology.

The event is co-organised by the European Business Technology Centre (EBTC), the European Patent Office (EPO) and the Association of Biotechnology-Led Enterprises (ABLE)

There is no registration fee, but places are limited, and we would therefore appreciate to receive your nominations by return e-mail before 10 March on This email address is being protected from spambots. You need JavaScript enabled to view it. .

Additional information